A Substance P Antagonist Reduces Axonal Injury and Improves Neurologic Outcome When Administered Up to 12 Hours after Traumatic Brain Injury

Mechanisms of cerebral edema in traumatic brain injury: therapeutic developments

(2010) James J Donkin et al.   CURRENT OPINION IN NEUROLOGY

Substance P antagonists as a therapeutic approach to improving outcome following traumatic brain injury

(2010) Robert Vink et al.   Neurotherapeutics

d-Cycloserine improves functional outcome after traumatic brain injury with wide therapeutic window

(2009) Amos Adeleye et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Substance P is Associated with the Development of Brain Edema and Functional Deficits after Traumatic Brain Injury

(2009) James J Donkin et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Lateralized spatial and object memory encoding in entorhinal and perirhinal cortices

(2009) P. S.F. Bellgowan et al.   LEARNING & MEMORY

Neurokinin-2 receptor antagonism in medial septum influences temporal-order memory for objects and forebrain cholinergic activity

(2009) S. Schäble et al.   PEPTIDES

Multifunctional drugs for head injury

(2008) Robert Vink et al.   Neurotherapeutics